Vivo Capital, LLC Delcath Systems, Inc. Transaction History
Vivo Capital, LLC
- $472 Million
- Q2 2025
A detailed history of Vivo Capital, LLC transactions in Delcath Systems, Inc. stock. As of the latest transaction made, Vivo Capital, LLC holds 569,526 shares of DCTH stock, worth $6.57 Million. This represents 1.64% of its overall portfolio holdings.
Number of Shares
569,526
Previous 750,195
24.08%
Holding current value
$6.57 Million
Previous $9.55 Million
18.89%
% of portfolio
1.64%
Previous 2.59%
Shares
8 transactions
Others Institutions Holding DCTH
# of Institutions
121Shares Held
13.2MCall Options Held
105KPut Options Held
38.7K-
Vanguard Group Inc Valley Forge, PA1.61MShares$18.6 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY813KShares$9.38 Million0.25% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il803KShares$9.27 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA703KShares$8.11 Million0.0% of portfolio
-
Marshall Wace, LLP London, X0483KShares$5.58 Million0.01% of portfolio
About DELCATH SYSTEMS, INC.
- Ticker DCTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 8,597,680
- Market Cap $99.2M
- Description
- Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...